Checkerspot
BiotechnologyWebsite
Checkerspot valuation and funding history | Last updated: November 25, 2025 | 4 funding rounds
Current Valuation
N/A
As of November 25, 2025
Total Funding Raised
$157.0M
Across 4 rounds
Last Round
Later Stage VC
$7.6M
Last Funding
Nov 2025
Funding date
Capital Efficiency
N/A
Valuation / Funding
Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| N/A | Unknown | Undisclosed | N/A | - |
| August 19, 2020 | Early Stage VC (Series B) | $36.0M | N/A | - |
| April 16, 2019 | Early Stage VC (Series A) | $13.0M | N/A | - |
| May 10, 2018 | Seed Round | $5.4M | N/A | - |
Valuation Analysis
Current Valuation Metrics
Checkerspot is currently valued at N/A as of November 25, 2025. The company has raised a total of $157.0M in funding across 4 funding rounds.
What is Checkerspot Worth in 2026?
Checkerspot is a leading private company in the Biotechnology sector. Track Checkerspot's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How Checkerspot Valuation is Determined
Private company valuations like Checkerspot's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.